Bliss GVS Pharma

124.10
+1.26
(1.03%)
ann
There are 2 new updates from the company23 hours ago
Viewcross
right
Market Cap
1,307.17 Cr
EPS
7.23
PE Ratio
16.10
Dividend Yield
0.40 %
Industry
Healthcare
52 Week High
185.50
52 Week Low
92.15
PB Ratio
1.28
Debt to Equity
0.11
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,764.75 4,23,422.64 36.32 49,887.20 12.06 9,648 13.77 61.58
5,840.65 1,55,050.91 75.90 8,184.00 0.89 1,600 64.53 55.23
1,511.20 1,22,046.63 24.67 26,520.70 14.17 4,155 47.38 60.28
3,245.05 1,09,827.24 59.25 10,785.70 11.59 1,656 13.54 61.68
2,398.05 98,935.61 47.95 10,615.60 19.57 1,942 -16.38 56.07
1,177.90 98,285.26 18.80 28,905.40 12.36 5,578 1.69 51.86
2,068.75 94,375.87 33.76 20,141.50 19.94 1,936 38.82 54.50
907.35 91,300.64 20.56 19,831.50 13.82 3,831 29.92 48.54
1,194.95 69,402.89 19.93 29,559.20 17.55 3,169 -10.04 61.05
31,101.85 66,089.26 49.48 6,097.20 10.80 1,201 16.01 61.04
Growth Rate
Revenue Growth
3.85 %
Net Income Growth
6.39 %
Cash Flow Change
344.33 %
ROE
-2.75 %
ROCE
-2.81 %
EBITDA Margin (Avg.)
27.85 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
100
184
138
148
146
162
235
241
226
239
198
173
219
253
217
247
214
223
153
139
137
154
168
138
176
201
222
179
196
175
211
188
165
225
206
204
188
223
226
Expenses
60
132
104
95
101
126
187
182
161
179
148
164
165
187
177
212
163
185
115
117
110
120
126
115
134
167
256
147
150
148
158
179
135
158
157
199
149
176
181
EBITDA
40
51
34
52
46
36
48
60
65
61
50
9
55
66
40
35
51
38
39
21
27
35
42
23
42
35
-33
32
46
27
53
9
29
67
49
5
39
47
45
Operating Profit %
36 %
25 %
21 %
34 %
27 %
21 %
18 %
27 %
28 %
20 %
25 %
2 %
20 %
18 %
20 %
13 %
23 %
12 %
22 %
2 %
15 %
21 %
23 %
13 %
21 %
15 %
-18 %
12 %
21 %
14 %
23 %
3 %
15 %
26 %
22 %
-0 %
19 %
19 %
14 %
Depreciation
3
6
3
2
4
4
11
1
5
5
7
5
2
2
2
2
3
4
3
3
4
4
4
4
4
4
4
4
5
5
5
5
6
6
7
7
7
7
8
Interest
5
5
2
7
4
4
4
8
7
6
5
5
1
1
1
1
1
1
1
5
2
0
1
2
1
1
1
2
2
2
1
5
2
2
2
2
2
4
1
Profit Before Tax
33
41
31
43
41
36
38
60
56
52
39
-1
51
63
37
32
47
34
34
13
20
30
37
17
37
30
-39
27
39
20
47
-1
22
59
40
-4
30
36
36
Tax
13
13
7
15
13
15
17
18
19
12
13
12
12
21
9
13
14
3
9
8
4
8
10
8
11
8
10
3
12
4
18
-4
7
16
11
1
8
10
11
Net Profit
20
28
24
29
28
21
22
43
37
40
26
-14
39
42
27
19
33
31
26
6
17
22
28
8
26
22
-49
24
28
16
30
4
14
43
29
-5
22
26
26
EPS in ₹
1.89
2.23
2.15
1.71
2.67
2.46
2.02
3.21
2.05
4.93
1.74
-1.39
3.72
4.02
2.50
1.76
3.28
3.00
2.30
0.85
1.57
1.99
2.48
0.61
2.35
2.05
-4.83
1.90
2.48
1.33
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
Fixed Assets
234
225
305
143
146
242
234
282
379
370
Current Assets
417
471
566
690
694
770
765
777
697
812
Capital Work in Progress
0
9
4
1
47
0
2
22
3
8
Investments
0
0
0
0
0
0
0
2
8
4
Other Assets
428
527
714
717
712
786
840
803
768
832
Total Liabilities
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
Current Liabilities
243
267
437
299
207
231
204
233
193
160
Non Current Liabilities
68
50
33
13
38
46
45
29
46
51
Total Equity
352
446
553
548
660
750
828
847
917
1,003
Reserve & Surplus
327
402
476
526
636
725
798
808
874
957
Share Capital
10
10
10
10
10
10
10
10
10
11

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-34
23
30
-11
-22
0
-2
9
3
-1
Investing Activities
-30
-50
-249
48
-79
-40
-45
-103
-6
-133
Operating Activities
38
113
290
18
40
47
64
136
34
152
Financing Activities
-42
-40
-10
-76
17
-6
-21
-24
-25
-21

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
33.31 %
33.24 %
33.19 %
33.14 %
33.14 %
34.51 %
34.55 %
34.46 %
35.04 %
35.12 %
35.06 %
34.97 %
34.97 %
34.90 %
34.82 %
35.10 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.31 %
0.00 %
14.73 %
13.25 %
12.13 %
13.51 %
DIIs
6.72 %
6.72 %
6.67 %
6.66 %
6.66 %
6.65 %
6.64 %
6.63 %
6.63 %
6.62 %
6.61 %
6.59 %
6.59 %
6.58 %
6.57 %
6.55 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.45 %
26.90 %
27.59 %
28.26 %
30.37 %
30.15 %
30.57 %
30.74 %
30.00 %
30.10 %
29.17 %
30.78 %
31.71 %
32.84 %
34.57 %
32.93 %
Others
36.52 %
33.14 %
32.55 %
31.95 %
29.84 %
28.69 %
28.24 %
28.18 %
28.33 %
28.15 %
12.84 %
27.66 %
12.00 %
12.43 %
11.92 %
11.91 %
No of Share Holders
28,543
39,999
42,742
41,080
45,866
46,327
45,753
44,983
43,041
42,182
43,234
40,758
45,157
44,737
52,937
49,558

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.6 1 1 0.5 0.5 0.5 0.5 0.5 0.00
Dividend Yield (%) 0.00 0.31 0.56 0.99 0.51 0.65 0.71 0.44 0.41 0.00

Corporate Action

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
23 hours ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
23 hours ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
1 day ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 21, 2025
Integrated Filing (Financial)
Jan 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 29, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024
Jan 28, 2025
Board Meeting Outcome for Outcome Of Board Meeting
Jan 28, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 And Other Business Matters.
Jan 21, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Jan 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Jan 07, 2025
Change Of Name Of Companys Registrar And Transfer Agent (RTA) From Link Intime India Private Limited To MUFG Intime India Private Limited
Jan 02, 2025
Closure of Trading Window
Dec 31, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dec 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 06, 2024
Intimation Regarding Certificate Of EU GMP Compliance For Company'S Manufacturing Facilities Situated At Plot 11 And Survey No. 43 & 44 At Palghar, Maharashtra, India
Nov 23, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Nov 15, 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Nov 07, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Oct 30, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Oct 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, October 24, 2024
Oct 24, 2024
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Yearly Ended September 30, 2024
Oct 17, 2024
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Yearly Ended September 30, 2024
Oct 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 04, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Oct 04, 2024
Closure of Trading Window
Sep 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 18, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Sep 12, 2024
Announcement under Regulation 30 (LODR)-Change in Management
Aug 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 27, 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Aug 22, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Aug 14, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 14, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 02, 2024
Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2016-2017 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority
Aug 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jul 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM
Jul 25, 2024
Proceedings Of The 39Th Annual General Meeting Held On Thursday, July 25, 2024
Jul 25, 2024
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024
Jul 24, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jul 18, 2024
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024
Jul 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 12, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Jul 09, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 05, 2024
Business Responsibility and Sustainability Reporting (BRSR)
Jul 03, 2024

Technical Indicators

RSI(14)
Neutral
44.33
ATR(14)
Less Volatile
6.56
STOCH(9,6)
Neutral
57.16
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.48
ADX(14)
Weak Trend
15.97
UO(9)
Bearish
35.58
ROC(12)
Downtrend And Accelerating
-3.01
WillR(14)
Neutral
-38.84